It’s that time of year again — when millions of Americans begin working on New Year’s resolutions that most likely…

ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced the…

A new study has also found that people with a higher body mass index (BMI) are more likely to develop dementia than those with a normal body weight.

According to the first study to quantify the proportion of cancers attributable to diabetes and high BMI published in The Lancet Diabetes & Endocrinology, diabetes and high BMI over 25 kg/m2 were the cause of 5.6 percent of new cancer cases worldwide.

Obesity Rate in UAE is Estimated to be Twice the Worldwide Rate San Clemente, Calif., December 13, 2017 – ReShape…

ReShape Lifesciences Inc. announced today that their ReShape Integrated Dual Balloon technology has been granted employee coverage through a supplemental coverage policy at a multinational telecommunications corporation that provides mobile telephone, fixed telephone and broadband subscription television services.

After decades of sharp increases in obesity, a newly published survey called ACTION (Awareness, Care & Treatment In Obesity Management)…

San Clemente, CA, November 14, 2017 – ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat…

ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced new data that was presented this week at the ObesityWeek 2017 conference in Washington D.C.

According to a report by the U.S. Centers for Disease Control and Prevention (CDC), about 630,000 people in the United States were diagnosed with a cancer associated with being overweight or obese in 2014.